Results 251 to 260 of about 1,306,270 (351)

Feasibility and clinical value of pyloric functional luminal imaging probe in an infant

open access: yesJPGN Reports, Volume 7, Issue 1, Page 59-63, February 2026.
Abstract Pyloric dysfunction is becoming increasingly recognized as a cause of gastroparesis, but its diagnostic and therapeutic role in infants has not been well studied. Identification and treatment of pyloric dysfunction with functional luminal imaging probe (FLIP) technology or use of pyloric inhibition are not routinely used in infants due to lack
Ariel Porto   +3 more
wiley   +1 more source

Thyrotoxic Hypokalemic Periodic Paralysis: Pathophysiological Mechanisms. [PDF]

open access: yesEndocrinol Metab (Seoul)
Qing G   +5 more
europepmc   +1 more source

Multidisciplinary Team‐Assisted Rescue of Innominate Artery Hemorrhage During Tracheotomy for Bilateral Vocal Cord Paralysis Post‐Thyroidectomy for Thyroid Cancer: A Case Report and Scoping Literature Review

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 1, February 2026.
ABSTRACT Objectives The purpose of this study is to present a case of innominate artery (IA) rupture during tracheotomy, along with its prevention and emergency management. We also conducted a scoping review of the literature on IA hemorrhage during tracheotomy.
Jiang‐Tao Zhong   +4 more
wiley   +1 more source

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo   +11 more
wiley   +1 more source

Botulism in a Dog Fed a Raw Meat-Based Diet: A Case Report. [PDF]

open access: yesMicroorganisms
Viegas FM   +7 more
europepmc   +1 more source

Introduction to the Supplement

open access: yesMuscle &Nerve, Volume 73, Issue S1, Page S3-S6, February 2026.
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neuromuscular disease with marked phenotypic and clinical heterogeneity. Three active pharmaceutical agents are currently approved by the United States Food and Drug Administration (FDA) for ALS: riluzole, edaravone (including intravenous [IV] and oral suspension formulations), and
Kelly G. Gwathmey, Stephen Apple
wiley   +1 more source

Home - About - Disclaimer - Privacy